Vue transversale de la maladie
Myopathies
Un même point d’entrée pour les études cliniques, les découvertes scientifiques, les publications et les pistes exploratoires présentes dans Biomedical Watch.
Périmètre
Filtrer toute la vue
Chaque choix s’applique immédiatement aux quatre sections. Le filtre « type de SEP » n’apparaît que lorsque la sclérose en plaques est sélectionnée.
1028 résultats correspondants
· 46 visibles sur cette page
dans le périmètre Myopathies
Niveau clinique
Études et traitements 434
Interventions, programmes et essais cliniques rattachés au périmètre sélectionné.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Adult and Juvenile Myositis NCT00017914 · NCT00017914 | Myopathies | Ralentissement de la progression · Immunomodulation · Traitement symptomatique… | À vérifier | RECRUITING | This study will evaluate subjects with adult- and childhood-onset myositis… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:43 | Détail |
| Botulinum toxin type A NCT05720065 · Peripheral TMD Pain Mechanisms and the Effect by Botulinum Toxin A | Myopathies | Traitement symptomatique | Phase 2 | RECRUITING | The main purpose of this study is to determine which is the best dose of a… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:43 | Détail |
| CovExc — Muscular Rehabilitation by Eccentric Exercise After Severe C… NCT04649086 · NCT04649086 | Myopathies | À vérifier | Non applicable | TERMINATED | With the COVID-19 pandemic, the number of patients to be treated in rehabi… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:43 | Détail |
| Effectiveness of Conservative Interventions in the Treatment of Trigg… NCT06296017 · NCT06296017 | Myopathies | À vérifier | Non applicable | RECRUITING | There is no study in the literature comparing the effectiveness of ESWT an… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:43 | Détail |
| Electrophysiological measurement of reflex nociceptive flexion thresh… NCT04624581 · FIbromyalgia anD GenetIcs Subgroups (FIDGIS) | Myopathies | Traitement symptomatique | Non applicable | COMPLETED | Fibromyalgia syndrome (FS) is characterized by widespread pain and affect… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:43 | Détail |
| Fascial Distortion Model NCT06627855 · Effectiveness of the Fascial Distortion Model in Temporomandibular Disorders: A… | Myopathies | Ralentissement de la progression · Traitement symptomatique | Non applicable | RECRUITING | The aim of the study was to investigate the effectiveness of Manual Therap… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:43 | Détail |
| Intravenously administered pooled human immunoglobulin (IVIG) NCT06599697 · The MIGHT Trial - An Exploratory Clinical Trial of IVIG in Anti-HMGCR Immune Med… | Myopathies | À vérifier | Phase 2 | RECRUITING | This is a randomized, placebo-controlled, double blinded phase 2 explorato… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:43 | Détail |
| LOLA — Effectiveness of Health Education Program on Musculoskeletal P… NCT07160478 · NCT07160478 | Myopathies | Traitement symptomatique | Non applicable | COMPLETED | Musculoskeletal pain during childhood can negatively affect school attenda… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:43 | Détail |
| Prospective, Longitudinal, Observational Registry of Adult Patients W… NCT05596539 · NCT05596539 | Myopathies | À vérifier | À vérifier | RECRUITING | The purpose of this study is to assess medical events during follow-up of… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:43 | Détail |
| Real radial extracorporeal shock wave therapy (rESWT) NCT07476690 · CP-rESWT-FREQ — Effect of rESWT Session Frequency on Spasticity and Function Ass… | Myopathies | Traitement symptomatique | Non applicable | COMPLETED | Spasticity is a major contributor to functional limitations in children wi… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:43 | Détail |
| SeMAFor — Magnesium, Stress and Fibromyalgia NCT03887000 · NCT03887000 | Myopathies | Traitement symptomatique | Non applicable | COMPLETED | Fibromyalgia affects an average of 2% of the French population. Data from… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:43 | Détail |
| AOC 1020 NCT05747924 · FORTITUDE — Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral… | Myopathies | À vérifier | Phase 1/2 | COMPLETED | A Randomized, Double-blind, Placebo-controlled, Phase 1/2 Study to Evaluat… À vérifier | ClinicalTrials.gov 2026-08-16 19:04:32 | Détail |
| BMN 351 NCT06280209 · A Phase 1/2 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Phar… | Myopathies | À vérifier | Phase 1/2 | ACTIVE_NOT_RECRUITING | This open-label extension study aims to evaluate the long-term safety and… À vérifier | ClinicalTrials.gov 2026-08-16 19:04:32 | Détail |
| EPI-321 NCT06907875 · FSHD — A First-in-human Study of EPI-321 in Facioscapulohumeral Muscular Dystrop… | Myopathies | Thérapie génique | Phase 1/2 | ACTIVE_NOT_RECRUITING | The goal of this clinical trial is to learn how safe and tolerable EPI-321… À vérifier | ClinicalTrials.gov 2026-08-16 19:04:32 | Détail |
| GNR-097 NCT07673809 · A Study to Evaluate the Tolerability, Safety and Efficacy of GNR-097 Gene Therap… | Myopathies | Thérapie génique | Phase 1/2 | RECRUITING | The study will evaluate the tolerability, safety and efficacy of gene ther… À vérifier | ClinicalTrials.gov 2026-08-16 19:04:32 | Détail |
| PBGENE-DMD (IV) NCT07429240 · PBGENE-DMD Phase 1/2a Safety and Preliminary Efficacy Study in Duchenne Muscular… | Myopathies | À vérifier | Phase 1/2 | RECRUITING | The purpose of this Phase 1/2a trial is to evaluate the safety, tolerabili… À vérifier | ClinicalTrials.gov 2026-08-16 19:04:32 | Détail |
| SGT-003 NCT06138639 · A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE) | Myopathies | Thérapie génique | Phase 1/2 | RECRUITING | This is a Phase 3, double-blind, placebo-controlled study with the primary… À vérifier | ClinicalTrials.gov 2026-08-16 19:04:32 | Détail |
| ASP2957 NCT07052929 · Study of ASP2957 in Male Participants With X-linked Myotubular Myopathy Who Need… | Myopathies | Traitement symptomatique · Thérapie génique | Phase 1/2 | RECRUITING | X-linked myotubular myopathy (XLMTM) is a rare and serious condition prese… À vérifier | ClinicalTrials.gov 2026-08-16 19:04:31 | Détail |
| CT103A NCT07752264 · A Phase I/II Study of Eque-cel in Subjects Withimmune-mediated Necrotizing Myopa… | Myopathies | Thérapie cellulaire | Phase 1/2 | NOT_YET_RECRUITING | CAR-T autologue anti-BCMA (CT103A / equecabtagene autoleucel) visant les c… À vérifier | ClinicalTrials.gov NCT04561557 ; Cell 2025 (Qin et al.… 2026-08-16 19:04:31 | Détail |
| NKX019 NCT06733935 · A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2) | Myopathies | À vérifier | Phase 1/2 | RECRUITING | Primary objective: Safety and tolerability of NKX019, administered after l… À vérifier | ClinicalTrials.gov 2026-08-16 19:04:31 | Détail |
Découverte scientifique
Recherches et trouvailles 0
Projets précliniques, publications émergentes et programmes de recherche suivis dans le pipeline.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Aucune trouvaille ne correspond aux filtres. | |||||||
Bibliographie
Publications 588
Références bibliographiques de la base locale et accès à leur source originale.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| New Cortisol Thresholds for the Diagnosis of Adrenal Insufficiency Us… Chronic Corticosteroid Therapy · PMID 41975776 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source The low-dose Synacthen stimulation test (LD-SST) is the reference dynamic test for diagnosing glucocorticoid-induced ad… | Diagnostics (Basel, Switzerland) 2026-07-08 20:15:00 | Source |
| Very late stent thrombosis associated with stent malapposition and un… Chronic Corticosteroid Therapy · PMID 41972237 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source Kounis syndrome (KS) is an acute coronary syndrome triggered by allergic or hypersensitivity reactions and is classifie… | European heart journal. Case reports 2026-07-08 20:15:00 | Source |
| Investigation of the relationship between dual-task performance and f… Fear of Falling in Muscular Dystrophy · PMID 40107171 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source The aim of this study is to investigate the variations in dual-task performance between children with Duchenne Muscular… | Research in developmental disabilities 2026-07-08 20:14:58 | Source |
| Tests of dynamic balance, motor function and fear of falling as indic… Fear of Falling in Muscular Dystrophy · PMID 40645042 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source This study aims to examine dynamic balance, motor function, and fear of falling (FOF) as indicators of fall risk in chi… | European journal of paediatric neurology : EJPN : offi… 2026-07-08 20:14:58 | Source |
| New insights into an old vaccine: potency and breadth of neutralizing… Yellow Fever vaccine (17D) · PMID 40766119 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source The yellow fever vaccine 17D has controlled yellow fever for almost 90 years and is considered highly successful. Howev… | medRxiv : the preprint server for health sciences 2026-07-08 20:14:57 | Source |
| New insights into an old vaccine: potency and breadth of neutralizing… Yellow Fever vaccine (17D) · PMID 41670061 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source The yellow fever vaccine 17D has controlled yellow fever for almost 90 years and is considered highly successful. Howev… | The Journal of infectious diseases 2026-07-08 20:14:57 | Source |
| Early mobilization in the neurotrauma intensive care unit: a service… The Impact of Early Mobilization Protocol in Patients in the ICU · PMID 42388707 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source Early mobilization (EM) refers to active exercise commenced while patients are on the intensive care unit (ICU). Althou… | Frontiers in neurology 2026-07-08 20:14:56 | Source |
| Nursing-led stepwise pain-management protocol improves postoperative… The Impact of Early Mobilization Protocol in Patients in the ICU · PMID 42007103 | Myopathies | Traitement symptomatique | Publication | PubMed | Voir la publication source To assess the impact of a stepwise pain-management protocol on postoperative recovery, pain control, complication rate,… | American journal of translational research 2026-07-08 20:14:56 | Source |
| Experiences of women with disabilities accessing maternal and newborn… Awareness Levels of Caregivers of Disabled Children · PMID 42192434 | Myopathies | Ralentissement de la progression · Thérapie génique | Publication | PubMed | Voir la publication source Despite global commitments to inclusive and equitable maternal and newborn health (MNH) care, women with disabilities i… | Reproductive health 2026-07-08 20:14:50 | Source |
| The effect of a mindfulness-based stress reduction program on stress… Awareness Levels of Caregivers of Disabled Children · PMID 42297152 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source Mothers of children with physical disabilities often experience caregiving-related stress that may negatively affect th… | Journal of affective disorders 2026-07-08 20:14:50 | Source |
| One-day rejuvenation: a preliminary case series of a multimodal proto… Botulinum toxin type A · PMID 42418230 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source Same-day multimodal aesthetic treatments may optimize patient convenience, but concerns remain regarding possible therm… | Journal of cosmetic and laser therapy : official publi… 2026-07-08 20:14:49 | Source |
| Activation of GABAR alleviates colitis by reprogramming macrophage po… baclofen · PMID 42413737 | Myopathies | Immunomodulation | Publication | PubMed | Voir la publication source Although the metabotropic GABA type B receptor (GABAR) has emerged as an immune modulator, its specific role in regulat… | Biochemical pharmacology 2026-07-08 20:14:47 | Source |
| Long-Term Effects of Early Postnatal Administration of R-Baclofen on… baclofen · PMID 42411441 | Myopathies | Traitement symptomatique | Publication | PubMed | Voir la publication source Contactin-associated protein-like 2 () is a highly expressed gene during development, coding for the cell adhesion mole… | Journal of integrative neuroscience 2026-07-08 20:14:47 | Source |
| Intermittent Theta-Burst Stimulation and Depressive Symptoms in Major… Intermittent theta burst stimulation · PMID 42418203 | Myopathies | Traitement symptomatique | Publication | PubMed | Voir la publication source Intermittent theta-burst stimulation (iTBS) is an established treatment for major depressive disorder (MDD), but sham-c… | JAMA network open 2026-07-08 20:14:19 | Source |
| Intermittent Theta-Burst Stimulation for Depression-Delineating Speci… Intermittent theta burst stimulation · PMID 42418204 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source Résumé non disponible dans la base locale. | JAMA network open 2026-07-08 20:14:19 | Source |
| Feasibility and behavioral impact of a wearable-supported digital hea… test of walk · PMID 42416388 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source This proof-of-concept study examined whether wearable devices integrated with the Welloop mobile application and a ligh… | Digital health 2026-07-08 15:43:04 | Source |
| Five-Year Outcomes of Paclitaxel-Coated Balloons in Patients with Dia… test of walk · PMID 42416524 | Myopathies | Thérapie génique | Publication | PubMed | Voir la publication source Long-term outcomes of paclitaxel-coated drug-coated balloons (DCBs) in patients with diabetes mellitus (DM) and infrain… | Vascular health and risk management 2026-07-08 15:43:04 | Source |
| Disparities in deworming coverage between children with and without d… COVID-19 Pandemic and Parents of Disabled Children · PMID 42264499 | Myopathies | Ralentissement de la progression | Publication | PubMed | Voir la publication source Children with disabilities experience lower school enrolment rates and may be systematically excluded from school-based… | BMJ global health 2026-07-08 12:06:58 | Source |
| Neurodevelopmental treatment needs after severe acute respiratory syn… COVID-19 Pandemic and Parents of Disabled Children · PMID 42050906 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source ObjectiveThis cohort study examined whether documented coronavirus disease 2019 in young children affects the need for… | The Journal of international medical research 2026-07-08 12:06:58 | Source |
| Aquatic training improves muscle strength and functional mobility in… Manual muscular test · PMID 42398272 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source Myotonic dystrophy type 1 (DM1) is the most common adult muscular dystrophy and is characterized by progressive muscle… | Neuromuscular disorders : NMD 2026-07-08 12:06:57 | Source |
Exploration — prudence
Pistes exploratoires 6
Rapprochements mécanistiques et hypothèses de recherche : ils ne constituent pas une preuve d’efficacité ni une recommandation thérapeutique.
Hypothèses non validéesÀ confirmer par des travaux précliniques, cliniques et une revue scientifique indépendante.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| N-PPG N-PPG — modulation métabolique cérébrale | Myopathies | Remyélinisation indirecte / réparation · Neuroprotection | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation métabolique et mitohormèse N-PPG est étudié dans Maladie de Huntington et documente plusieurs axes biologiques pouvant être pertinents pour Myopat… | Rapprochement Biomedical Watch · Maladie de Huntington | Détail |
| Vecteur Ple389 (ADORA2A) MiniPromoter Ple389 — ciblage striatal | Myopathies | Thérapie génique | Hypothèse exploratoire | Rapprochement automatique non validé | Expression génique ciblée dans les neurones striataux Vecteur Ple389 (ADORA2A) est étudié dans Maladie de Huntington et documente plusieurs axes biologiques pouvant être per… | Rapprochement Biomedical Watch · Maladie de Huntington | Détail |
| α-Amyrin α-Amyrin — protection mitochondriale | Myopathies | Remyélinisation indirecte / réparation · Neuroprotection | Hypothèse exploratoire | Rapprochement automatique non validé | Protection mitochondriale et modulation de la pathologie Tau α-Amyrin est étudié dans Maladie d’Alzheimer et documente plusieurs axes biologiques pouvant être pertinents pour Myopa… | Rapprochement Biomedical Watch · Maladie d’Alzheimer | Détail |
| 4-octyl itaconate et dérivés Dérivés de l’itaconate — neuroinflammation | Myopathies | Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation immunométabolique de la microglie 4-octyl itaconate et dérivés est étudié dans Sclérose latérale amyotrophique et documente plusieurs axes biologiques po… | Rapprochement Biomedical Watch · Sclérose latérale amy… | Détail |
| Thonningianin A Thonningianin A — neuroprotection anti-amyloïde | Myopathies | Neuroprotection | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation du stress oxydatif et des protéines associées à Alzheimer Thonningianin A est étudié dans Maladie d’Alzheimer et documente plusieurs axes biologiques pouvant être pertinents pou… | Rapprochement Biomedical Watch · Maladie d’Alzheimer | Détail |
| Vutiglabridin Vutiglabridin — autophagie et PON2 | Myopathies | Neuroprotection | Hypothèse exploratoire | Rapprochement automatique non validé | Activation de PON2 et stimulation de l’autophagie Vutiglabridin est étudié dans Maladie d’Alzheimer et documente plusieurs axes biologiques pouvant être pertinents pour… | Rapprochement Biomedical Watch · Maladie d’Alzheimer | Détail |